Dynavax Technologies
DVAX
#4962
Rank
S$2.29 B
Marketcap
S$19.58
Share price
0.00%
Change (1 day)
9.31%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -S$48.58 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are S$0.33 Billion. In 2024 the company made an earning of S$47.55 Million, an increase over its 2023 earnings that were of S$3.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$48.58 Million-202.14%
2024 S$47.55 M1475.31%
2023 S$3.01 M-99.2%
2022 S$0.37 B238.78%
2021 S$0.11 B-257.89%
2020 -S$70.97 Million-58.58%
2019 -S$0.18 Billion-9.32%
2018 -S$0.19 Billion60.44%
2017 -S$0.12 Billion-15.8%
2016 -S$0.14 Billion4.22%
2015 -S$0.14 Billion16.54%
2014 -S$0.12 Billion37.09%
2013 -S$83.99 Million
2010 -S$60.12 Million214.85%
2009 -S$19.1 Million-37.33%
2008 -S$30.47 Million-66.07%
2007 -S$89.8 Million16.92%
2006 -S$76.81 Million170.36%
2005 -S$28.41 Million33.39%
2004 -S$21.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$14.97 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.41 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.40 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.48 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.16 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.53 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$11.77 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
S$26.1 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.71 B-6,450.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel